Genomic analysis and personalized preclinical model development to identify novel therapeutic targets and determinants of drug response in soft-tissue sarcomas characterized by chromatin regulator-associated abnormalities
Ente Finanziatore: Direzione Scientifica Fondazione IRCCS Istituto Nazionale dei Tumori, fondi per la ricerca istituzionale
Principal Investigator: Dott.ssa Frezza Anna Maria
Struttura Principale: Oncologia Medica 2
Genomic analysis and personalized preclinical model development to identify novel therapeutic targets and determinants of drug response in soft-tissue sarcomas characterized by chromatin regulator-associated abnormalities
Principal Investigator Dott.ssa Frezza Anna Maria
Struttura Principale: Oncologia Medica 2
Area Clinica, Struttura complessa
Ultimo aggiornamento: 09/07/2025
